Biotechnology Stocks I Performance Guide: Ligand Pharmaceuticals Incorporated (LGND)
LGND has no dividends.
Table and Chart of LGND Performance
See what a $1,000 investment in LGND is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| LGND Returns | |
|---|---|
| Start Date | Jul-31-2014 |
| Start Price | $49.17 |
| End Date | Jul-26-2024 |
| End Price | $107.14 |
| # Prices | 121 |
| Min Date | Sep-30-2014 |
| Min Price | $46.99 |
| Max Date | Sep-28-2018 |
| Max Price | $274.49 |
| Total Return | 117.90% |
| Annualized Return | 8.03% |
| Current Value of $1,000 Purchase | $2,179 |
| Number Returns | 7,260 |
| Average Return | 9.50% |
| Number Profitable Returns | 3,305 |
| Percent Profitable Returns | 45.52% |
| Number Unprofitable Returns | 3,955 |
| Percent Unprofitable Returns | 54.48% |
| Profitable to Unprofitable Returns Ratio | 0.84 |
| LGND Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,904,332,000 |
| Beta | 0.918 | Price to Sales | 13.02 |
| Earnings per Share | $5.3500 |
| PE Ratio | 19.82 |
| PE to Growth Ratio | 1.527 |
| Price to Book | 1.91 |
| PRICE DATA | |
| 52 Week High | $108.91 |
| 52 Week Low | $49.24 |
| Analyst Target Price | $117.8 |
| 50-Day Moving Average | $87.45 |
| 200-Day Moving Average | $73.26 |
| FINANCIAL DATA | |
| Revenue per Share | $6.77 |
| Revenue | $118,313,000 |
| Profit Margin | 81.4% |
| Return on Equity | 13.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
LGND Compare Returns with S&P 500
LGND Trendline Chart
LGND Moving Average Chart
LGND Stock Return Map - See Patterns of Gains and Losses
LGND Stock Returns/Purchase Dates